SoftBank Group’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

SoftBank Group’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,100,078	Closed	-$3.09M	–	31
2023 Q1	$3.09M	Buy	+12,100,078	New	+$10.9M	0.04%	26

SoftBank Group's PEAR Position: Q2 2023 in Review

SoftBank Group sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 12,100,078 shares — an estimated $3.09M sold.

SoftBank Group first reported a position in PEAR in Q1 2023 and held it in 1 quarter. The position peaked at $3.09M in Q1 2023. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

SoftBank Group reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
SoftBank Group sold 12,100,078 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $3.09M.
SoftBank Group first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q1 2023 and held it in 1 quarter.
SoftBank Group's Pear Therapeutics, Inc. Class A Common Stock position peaked at $3.09M in Q1 2023.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on SoftBank Group's 13F filing for Q2 2023, filed 14 Aug 2023.